Biopharmaceutical firm Abbisko kicked off bookbuilding for its Hong Kong IPO on Thursday, aiming to raise HK$1.75bn ($225.2m). The Shanghai-based company specialises in the discovery and development …
( read original story …)
The Shanghai News
Biopharmaceutical firm Abbisko kicked off bookbuilding for its Hong Kong IPO on Thursday, aiming to raise HK$1.75bn ($225.2m). The Shanghai-based company specialises in the discovery and development …
( read original story …)